Patents by Inventor Richard N. Kitsis

Richard N. Kitsis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11938128
    Abstract: Compounds, compositions and method of using these compounds are disclosed for treating a disease or disorder in which it is desirable to inhibit BAX, such as a cardiovascular disease or disorder.
    Type: Grant
    Filed: March 9, 2018
    Date of Patent: March 26, 2024
    Assignees: Albert Einstein College of Medicine, The University of Manitoba
    Inventors: Evripidis Gavathiotis, Richard N. Kitsis, Thomas P. Garner, Dulguun Amgalan, Lorrie Kirshenbaum, Felix Kopp
  • Patent number: 11813268
    Abstract: Activators of mitofusins and their uses in treatment of diseases and disorders are disclosed.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: November 14, 2023
    Assignee: Albert Einstein College of Medicine
    Inventors: Evripidis Gavathiotis, Richard N. Kitsis, Nikolaos Biris, Emmanouil Zacharioudakis
  • Publication number: 20200261469
    Abstract: Activators of mitofusins and their uses in treatment of diseases and disorders are disclosed.
    Type: Application
    Filed: October 16, 2018
    Publication date: August 20, 2020
    Inventors: Evripidis Gavathiotis, Richard N. Kitsis, Nikolaos Biris, Emmanouil Zacharioudakis
  • Publication number: 20200009132
    Abstract: Compounds, compositions and method of using these compounds are disclosed for treating a disease or disorder in which it is desirable to inhibit BAX, such as a cardiovascular disease or disorder.
    Type: Application
    Filed: March 9, 2018
    Publication date: January 9, 2020
    Inventors: Evripidis Gavathiotis, Richard N. Kitsis, Thomas Peter Garner, Dulguun Amgalan, Lorrie Kirshenbaum, Felix Kopp